We are live on
!
Find out more
NCM
Northroad Capital Management Portfolio holdings
AUM
$43.8M
1-Year Est. Return
163.34%
This Fund
S&P 500
This Quarter
Est. Return
-1.21%
1 Year Est. Return
+163.34%
3 Year Est. Return
+160.29%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$221M
AUM Growth
-$37.8M
(-15%)
Cap. Flow
-$24.2M
Cap. Flow
% of AUM
-10.95%
Top 10 Holdings %
Top 10 Hldgs %
34.74%
Holding
57
New
4
Increased
4
Reduced
46
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TE Connectivity
TEL
|
+$6.69M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$961K |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$447K |
| 4 |
SLB Ltd
SLB
|
+$9.66K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CAJ
Canon, Inc.
CAJ
|
+$6.12M |
| 2 |
Petrobras
PBR
|
+$5.61M |
| 3 |
Novartis
NVS
|
+$3.53M |
| 4 |
Diageo
DEO
|
+$1.08M |
| 5 |
TotalEnergies
TTE
|
+$877K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.65% |
| 2 | Technology | 12.21% |
| 3 | Financials | 9.99% |
| 4 | Materials | 7.33% |
| 5 | Consumer Staples | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Diageo
DEO
$53.7B
| $9.72M | 4.39% |
85,228
-9,302
| -10% | -$1.08M |
|
|
2
Novartis
NVS
$297B
| $8.91M | 4.02% |
107,263
-42,606
| -28% | -$3.53M |
|
3
Teva Pharmaceuticals
TEVA
$41.4B
| $7.8M | 3.52% |
135,697
-11,174
| -8% | -$623K |
|
|
RDS.A
4
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $7.48M | 3.38% |
119,587
-12,150
| -9% | -$785K |
|
5
WPP
WPP
$5.82B
| $7.14M | 3.22% |
68,582
-6,925
| -9% | -$690K |
|
|
6
TE Connectivity
TEL
$62.3B
| $7.03M | 3.18% |
+111,216
| New | +$6.69M |
|
7
SAP
SAP
$239B
| $6.91M | 3.12% |
99,252
-10,345
| -9% | -$711K |
|
|
8
TotalEnergies
TTE
$190B
| $6.53M | 2.95% |
80,801,101,263
-8,774,906,350
| -10% | -$877K |
|
|
ITY
9
DELISTED
IMPERIAL TOBACCO GRP ADS(RP 2
ITY
| $6.4M | 2.89% |
73,157
-7,058
| -9% | -$618K |
|
10
Sanofi
SNY
$105B
| $6.4M | 2.89% |
140,281
-13,378
| -9% | -$649K |
|
|
SYT
11
DELISTED
Syngenta Ag
SYT
| $6.22M | 2.81% |
96,769
-9,547
| -9% | -$602K |
|
|
AKZOY
12
DELISTED
Akzo Nobel NV
AKZOY
| $6.05M | 2.73% |
265,249
-26,002
| -9% | -$593K |
|
13
GSK
GSK
$106B
| $5.84M | 2.64% |
109,317
-12,044
| -10% | -$674K |
|
|
AXA
14
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $5.63M | 2.54% |
246,103
-24,424
| -9% | -$559K |
|
15
CRH
CRH
$66.2B
| $5.62M | 2.54% |
234,037
-22,627
| -9% | -$512K |
|
16
Mitsubishi UFJ Financial
MUFG
$253B
| $5.57M | 2.51% |
1,006,673
-105,953
| -10% | -$590K |
|
17
HSBC
HSBC
$355B
| $5.45M | 2.46% |
133,828
-14,601
| -10% | -$623K |
|
18
Ericsson
ERIC
$33.4B
| $5.26M | 2.38% |
435,150
-41,460
| -9% | -$499K |
|
19
RELX
RELX
$63B
| $5.17M | 2.33% |
303,948
-29,708
| -9% | -$489K |
|
|
ABB
20
DELISTED
ABB Ltd
ABB
| $5.11M | 2.31% |
241,449
-24,605
| -9% | -$532K |
|
21
Barclays
BCS
$94.2B
| $4.56M | 2.06% |
326,530
-32,818
| -9% | -$450K |
|
|
CS
22
DELISTED
Credit Suisse Group
CS
| $4.41M | 1.99% |
175,889
-17,437
| -9% | -$457K |
|
23
BHP
BHP
$228B
| $4.4M | 1.99% |
109,897
-15,845
| -13% | -$731K |
|
24
ING
ING
$102B
| $4.3M | 1.94% |
331,859
-32,453
| -9% | -$451K |
|
|
TKP
25
DELISTED
TECHNIP ADS (EA REPTG ONE ORD SHS)
TKP
| $3.47M | 1.57% |
234,839
-1,628
| -0.7% | -$24.1K |
|
Similar funds
CC
RAM
ACI
QCM
NHG
RVGI
BS
BSCM
Northroad Capital Management's Q4 2014 Portfolio in Review
As of Q4 2014, Northroad Capital Management held 57 positions worth $221M, down 15% from $259M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Northroad Capital Management withdrew a net $24.2M in Q4 2014, closing 3 positions and reducing 46 holdings. Its most notable exit was Canon, Inc., an estimated $6.12M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Northroad Capital Management opened a new position in TE Connectivity worth $7.03M.
- Northroad Capital Management's largest Q4 2014 buy was TE Connectivity: 111,216 shares worth $7.03M.
- Northroad Capital Management added most to SLB Ltd in Q4 2014, an estimated $9.66K increase.
- Northroad Capital Management's biggest Q4 2014 reduction was Novartis, cutting an estimated $3.53M.
- Northroad Capital Management fully exited Canon, Inc. in Q4 2014, selling an estimated $6.12M.
- Northroad Capital Management's ten largest holdings make up 35% of its $221M portfolio in Q4 2014.
- Northroad Capital Management opened 4 new positions and closed 3 in Q4 2014.
- Northroad Capital Management's portfolio value fell 15% quarter-over-quarter to $221M.
Based on Northroad Capital Management's 13F filing for Q4 2014, filed 5 Feb 2015.